CSIMarket
 


Cba Florida Inc   (CBAI)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

CBAI's Capital Expenditures Growth by Quarter and Year

Cba Florida Inc 's Capital Expenditures results by quarter and year




CBAI Capital Expenditures (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - 0.00 0.00 0.00
III Quarter September - 0.00 0.00 0.00
II Quarter June - 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   0.00 0.00 0.00 0.00



CBAI Capital Expenditures first quarter 2020 Y/Y Growth Comment
Cba Florida Inc in the first quarter 2020 recorded Capital Expenditures of $ 0.00 millions.

According to the results reported in the first quarter 2020, Cba Florida Inc achieved the best Capital Expenditures growth in Medical Laboratories industry. While Cba Florida Inc ' s Capital Expenditures no change of % ranks overall at the positon no. in the first quarter 2020.




CBAI Capital Expenditures ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Cba Florida Inc 's first quarter 2020 Capital Expenditures $ 0.00 millions CBAI's Income Statement
Cba Florida Inc 's first quarter 2019 Capital Expenditures $ 0.00 millions Quarterly CBAI's Income Statement
New: More CBAI's historic Capital Expenditures Growth >>


CBAI Capital Expenditures (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Capital Expenditures first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Capital Expenditures first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Capital Expenditures by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Cba Florida Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CBAI's I. Quarter Q/Q Capital Expenditures Comment


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CBAI's I. Quarter Q/Q Capital Expenditures Comment


Cba Florida Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Capital Expenditures Growth (TTM) - - - - -
Year on Year Capital Expenditures Growth Overall Ranking # # # # #
Seqeuential Capital Expenditures Change (TTM) - - - - -
Seq. Capital Expenditures Growth (TTM) Overall Ranking # # # # #




Cumulative Capital Expenditures growth Comment
In the Mar 31 2020 period, Cba Florida Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Cba Florida Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Capital Expenditures growth Comment
In the Mar 31 2020 period, Cba Florida Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Cba Florida Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Capital Expenditures Growth
Medical Laboratories Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
CBAI's Capital Expenditures Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for CBAI's Competitors
Capital Expenditures Growth for Cba Florida Inc 's Suppliers
Capital Expenditures Growth for CBAI's Customers

You may also want to know
CBAI's Annual Growth Rates CBAI's Profitability Ratios CBAI's Asset Turnover Ratio CBAI's Dividend Growth
CBAI's Roe CBAI's Valuation Ratios CBAI's Financial Strength Ratios CBAI's Dividend Payout Ratio
CBAI's Roa CBAI's Inventory Turnover Ratio CBAI's Growth Rates CBAI's Dividend Comparisons



Companies with similar Capital Expenditures no change for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Mar 31 2020
Orasure Technologies Inc-1.26%$ -1.256 millions
Beigene ltd -1.35%$ -1.351 millions
Acadia Healthcare Company Inc -1.52%$ -1.516 millions
Carlisle Companies Incorporated-2.15%$ -2.146 millions
Spero Therapeutics Inc -2.47%$ -2.469 millions
Neuronetics inc -2.92%$ -2.920 millions
Myriad Genetics Inc -3.23%$ -3.226 millions
Celcuity Inc -4.28%$ -4.276 millions
Kaleido Biosciences Inc -4.53%$ -4.529 millions
Johnson and Johnson-4.73%$ -4.726 millions
Fibrogen Inc -4.97%$ -4.969 millions
Vanda Pharmaceuticals Inc -5.09%$ -5.089 millions
Tenet Healthcare Corp-5.15%$ -5.155 millions
Hanger inc.-5.38%$ -5.379 millions
Biolife Solutions Inc -6.41%$ -6.410 millions
Endologix Inc-6.54%$ -6.542 millions
Inspire Medical Systems inc -7.27%$ -7.273 millions
Kyto Technology And Life Science Inc -7.82%$ -7.819 millions
Intuitive Surgical Inc -8.36%$ -8.362 millions
Bristol myers Squibb Company-8.82%$ -8.824 millions
Dynatronics Corporation-8.92%$ -8.923 millions
Integrated Biopharma Inc-9.52%$ -9.524 millions
Viveve Medical Inc -10.06%$ -10.056 millions
Heska Corporation-10.26%$ -10.256 millions
Icu Medical Inc-10.45%$ -10.447 millions
Milestone Scientific Inc -11.92%$ -11.920 millions
Veracyte inc -13.07%$ -13.072 millions
Baxter International Inc -13.13%$ -13.131 millions
Blueprint Medicines Corporation-13.84%$ -13.842 millions
3m Company-15.09%$ -15.090 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com